Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Aclaris Therapeutics Inc. (ACRS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
MFN Partners

Farhad Nanji And Michael Demichele

1,500,000 $3,285 0.52%
2.
Vivo Capital

Albert Cha And Frank Kung

1,647,214 $3,607 0.33%
3.
Deerfield Management

James E. Flynn

3,983,025 $8,723 -33% 0.31%
4.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

2,028,000 $4,441 +20% 0.16%
5.
Millennium Management

Israel Englander

35,386 $77 +70% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$10.75 372,093 Director 1,911,573 2018-10-22 Filing
$14.00 7,100 Director 177,457 2018-10-04 Filing
$15.00 6,600 Director 170,357 2018-08-23 Filing
$15.97 6,250 Director 163,757 2018-08-15 Filing
$19.12 500 Director 500 2018-05-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.69 590,801 Large Shareholder 3,159,165 2019-06-27 Filing
$2.69 108,674 Large Shareholder 964,101 2019-06-27 Filing
$4.50 1,352 Large Shareholder 3,749,966 2019-06-26 Filing
$4.50 352 Large Shareholder 1,072,775 2019-06-26 Filing
$4.51 40,850 Large Shareholder 3,751,318 2019-06-25 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,245 $1 0%
2. 4,595 $5 0%
News See All